Aveanna Healthcare Holdings: Recent Results Have Me More Optimistic (Rating Upgrade)
Summarize this article with:
Crimson And Gold Research250 FollowersFollow5ShareSavePlay(13min)CommentsSummaryAveanna Healthcare Holdings is upgraded to Buy, reflecting improved profitability and resilient demand for home healthcare services.AVAH's Q4 2025 net income surged, but adjusted EPS was $0.17 due to one-time tax benefits and merger costs.FY 2026 revenue guidance of $2.54–$2.56 billion disappointed, while adjusted EBITDA guidance slightly exceeded consensus.Significant risks remain from high debt, Medicaid exposure, and integration of recent acquisitions, warranting a high-risk Buy stance. DragonImages/iStock via Getty Images This article serves as an update to my previous analysis of Aveanna Healthcare Holdings (AVAH). When I last wrote about the company in July of 2025, I rated its stock as a Hold citingThis article was written byCrimson And Gold Research250 FollowersFollowI have been involved in the financial world for over 25 years with experience as an advisor, teacher, and writer. I am a full believer in the free-market system and that financial markets are efficient with most stocks reflecting their real current value. The best opportunities for profits on individual stocks come from stocks that are less-widely followed by the average investor or from stocks that may not accurately reflect the opportunities that currently exist in their markets.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.